Protein L Bioassay for Homogeneous Antibody Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing serological methods for diagnosing the presence of specific soluble antibodies in bodily fluids, such as ELISA, require extensive washing steps and have high sensitivity and specificity but are time-consuming, while rapid tests lack sensitivity and specificity and often require separation steps.
Innovation Solution
A bioassay method using a pair of fluorophores capable of energy transfer, where one fluorophore is attached to an antigen and the other to a Fab binding moiety like protein L, allowing for homogeneous, separation-free detection of specific antibodies by forming a FRET pair upon binding, thereby minimizing epitope masking and enhancing signal intensity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If classical techniques like ELISA or EIA are used, then sensitivity and specificity are high, but hands-on time and complexity increase due to extensive washing and incubation steps
Solution Approach 1:
The patent employs a phase transition approach by using a homogeneous assay format that transitions from heterogeneous (requiring washing) to homogeneous (separation-free) detection. The FRET-based detection system allows the assay to be performed in solution without phase separation steps, eliminating time-consuming washing and incubation procedures while maintaining high sensitivity and specificity through energy transfer between donor and acceptor fluorophores.
Solution Approach 2:
The patent replaces mechanical washing steps with an optical detection system based on FRET. Instead of physically separating bound from unbound reagents through washing, the invention uses energy transfer between fluorophores to detect antibody-antigen complexes in solution, substituting mechanical separation with optical signal detection that provides equivalent or superior precision.
2Productivity
If rapid tests are used, then hands-on time is reduced, but sensitivity and specificity decrease
Solution Approach 1:
The patent introduces FRET as an intermediary detection mechanism that bridges the gap between rapid homogeneous assay format and high measurement precision. The energy transfer between donor and acceptor fluorophores serves as a sensitive intermediary signal that can detect low concentrations of antibodies quickly without requiring separation steps, thereby achieving both rapid detection and high sensitivity/specificity simultaneously.
Solution Approach 2:
The patent changes the detection parameter from traditional colorimetric or chemiluminescent signals to FRET-based optical energy transfer. This parameter change enables the assay to achieve high sensitivity and specificity in a homogeneous, separation-free format that can be performed rapidly, overcoming the limitations of conventional rapid tests while maintaining diagnostic accuracy.
3Quantity of substance
If antigen is labelled with multiple fluorophores using different activation methods, then both acceptor and donor can be attached, but epitope masking occurs preventing antibody recognition
Solution Approach 1:
The patent segments the labelling process by using a single fluorophore attachment method (NHS ester chemistry) rather than multiple different activation methods. This segmentation approach ensures that only one type of chemical reaction occurs, preventing epitope masking while still achieving both donor and acceptor labelling through controlled stoichiometry and molar ratios, thereby maintaining reliable antibody recognition.
Solution Approach 2:
The patent applies partial labelling by controlling the molar ratio of fluorophore to antigen and using excess antigen to ensure that not all antigen molecules are labelled, or that not all epitopes on each antigen molecule are masked. This partial action approach maintains sufficient unlabelled or partially labelled antigen molecules that retain full antibody binding capability, ensuring reliable detection while still achieving adequate signal intensity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases signal intensity (7-10 fold) and allows for the detection of specific antibodies with high sensitivity and specificity without the need for washing steps, making it suitable for diagnostic purposes in complex sample matrices.
Implementation Method 1
said energy donor and said energy acceptor or quencher form an energy transfer pair capable of energy transfer
Data Source
AI summary
This invention relates to bioassay method wherein the presence of a specific soluble antibody in a sample of a bodily fluid, plasma or serum, of an animal, including human, is qualitatively and/or quantitatively determined. The method employs, a first group labelled with an energy donor and a second group labelled with an energy acceptor; the first group, or second group, comprising an antigen of the soluble antibody and the second group, or first group, respectively, comprising a Fab binding moiety capable of binding to a Fab region of antibodies of said animal. The donor and the acceptor form an energy transfer pair capable of energy transfer. The invention further comprises a kit for the bioassay method.